Trademarkia Logo

Australia

AU$
Trademark Search
LUPKYNIS

View On IPO.GOV.AU

LUPKYNIS
Protected: Registered/protected

Last updated on 19 Jul 2021

Owner Info

Aurinia Pharmaceuticals Inc.

1203-4464 Markham Street

Victoria BC V8Z 7X8, CANADA

Serial Number

2156772 filed on 4 Jan 2021

Correspondent

Matthew R. Wilmot Stoel Rives LLP

760 SW Ninth Avenue, Suite 3000,

Portland OR 97205,

UNITED STATES OF AMERICA

LUPKYNIS

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis.

Mark Details

Serial Number

2156772

Registered On

4 Jan 2021

Renewal On

4 Jan 2031

Mark Type

FIGURATIVE

Priority Claim (Convention Details)

Date

9 Nov 2020

Mark Type

US

Legal History

Show more

Status DateAction Taken
19th Jul 2021Customer Amendment Made correspondence sent
19th Jul 2021Amendment to Address for Service Requested
19th Jun 2021International Registration in Australia Protected correspondence sent
18th Jun 2021IP Right Registration Published
18th Jun 2021Status change to Registered/Protected
10th Apr 2021Application Accepted correspondence sent
10th Apr 2021IP Right has been Examined
10th Apr 2021IP Right Acceptance Published
3rd Mar 2021Status change to Accepted
22nd Feb 2021Indexing details updated